Maviret, Eloctate & Alprolix newly registered for health insurance benefits from 1 June

Published: 2018-05-31 17:07:51

Updated: 2018-05-31 17:07:51

Chronic hepatitis C treatment Maviret and hemophilia treatments Eloctate & Alprolix will newly be added to the list of health insurance benefits from 1 June.

Sovaldi Tab and Harvoni Tab will voluntarily drop their price by half.

The Ministry of Health and Welfare has revised and issued the ‘Drug Insurance Benefits List and Upper Limit Price Table’ which includes articles above on the 28^th.

A...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.